期刊文献+

合并乙型肝炎病毒感染的肺癌患者肝功能损伤的研究进展 被引量:4

Hepatotoxicity in lung cancer patients with hepatitis B virus infection
原文传递
导出
摘要 原发性支气管肺癌(肺癌)和乙型肝炎病毒(HBV)感染在我国具有高流行率,合并HBV感染的肺癌患者较为常见。研究发现该类患者在抗肿瘤过程中肝功能损伤的发生率较未合并者高,其肝功能损伤具有特殊危险因素和发生机制。通过对近年来合并HBV感染肺癌患者的肝功能损伤现状、发生机制及防治措施进行综述,为临床早期预防、治疗提供依据。 Due to high prevalence of lung cancer and hepatitis B virus infection in China, lung cancer patients complicated with HBV infection are not rare. The incidence of liver function impairment in lung cancer patients with HBV infection is much higher than those without HBV infection. Some special risk factors and mechanism of liver function impairment in lung cancer patients with HBV infection have been reported. This article reviews the incidence, mechanism and treatment of liver function impairment in those patients so as to provide information for prevention and management of this condition.
出处 《中华全科医师杂志》 2018年第3期243-246,共4页 Chinese Journal of General Practitioners
关键词 肺肿瘤 肝炎病毒 乙型 肝功能损伤 Lung neoplasms Hepatitis B virus Liver injury
  • 相关文献

参考文献3

二级参考文献28

  • 1Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
  • 2Liang XF,Bi SL,Yang WZ,et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination[J].Vaccine,2009,27(47):6550-6557.
  • 3Lalazar G,Rund D,Shouval D.Screening,prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies[J].Br J Haematol,2007,136:699-712.
  • 4Yeo W,Chan PK,Zhong S,et al.Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy:a prospective study of 626 patients with identification of risk factors[J].J Med Virol,2000,62(3):299-307.
  • 5Lazdina U,AlheimM,Nystrom J,et al.Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent[J].J Gen Virol,2003,84(Pt 1):139-146.
  • 6Zhong S,Yeo W,Schroder C,et al.High hepatitis B virus(HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy[J].J Viral Hepat,2004,11(1):55-59.
  • 7Shamliyan TA,Mac Donald R,Shaukat A,et al.Antiviral therapy for adults with chronic hepatitis B:a systematic review for a National Institutes of Health Consensus Development Conference[J].Ann InternMe,2009,150(2):111-124.
  • 8Hsu C,Hsiung CA,Su IJ,et al.A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma:a randomized trial[J].Hepatology,2008,47(3):844-853.
  • 9Yeo W,Johnson PJ.Diagnosis,prevention and management of hepatitis B virus reactivation during anti cancer therapy[J].Hepatology,2006,43(2):209-220.
  • 10LU Feng-min ZHUANG Hui.Management of hepatitis B in China[J].Chinese Medical Journal,2009(1):3-4. 被引量:659

共引文献697

同被引文献34

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部